Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
6,335,412
-
Shares change
-
+1,785,487
-
Total reported value, excl. options
-
$31,479,128
-
Value change
-
+$8,780,369
-
Put/Call ratio
-
14.2%
-
Number of buys
-
26
-
Number of sells
-
-9
-
Price
-
$4.97
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q3 2016
54 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q3 2016.
ARGOS THERAPEUTICS INC - COM (ARGS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,335,412 shares
.
Largest 10 shareholders include WASATCH ADVISORS INC (3,228,741 shares), VANGUARD GROUP INC (735,381 shares), BlackRock Fund Advisors (395,383 shares), SANDERS MORRIS HARRIS INC. (241,512 shares), WALL STREET ASSOCIATES (185,097 shares), ALTRINSIC GLOBAL ADVISORS LLC (172,505 shares), STATE STREET CORP (158,869 shares), GEODE CAPITAL MANAGEMENT, LLC (148,230 shares), NORTHERN TRUST CORP (137,777 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (121,524 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.